Precision Molecular Pathology of Lung Cancer

Zusatztext

Provides the most updated knowledge on biomarker testing and molecular therapy of lung cancerDetails the molecular pathology of specific cell types Written by experts in the field

Autorenportrait

Philip T. Cagle, MDHouston Methodist HospitalDepartment of Pathology & Genomic Medicine6565 Fannin StHouston, TX 77030 Timothy C. Allen, MDThe University of Texas Medical Branch Department of Pathology301 University BoulevardGalveston, TX 77555 Mary Beth Beasley, MDMount Sinai HospitalDepartment of Pathology1468 Madison AvenueNew York, NY 10029 Lucian R. Chirieac, MDBrigham And Women's HospitalDepartment of Pathology75 Francis St.Boston, MA 02115 Sanja Dacic, MD, PhDUniversity of Pittsburgh Medical CenterDepartment of Pathology200 Lothrop St.Pittsburgh, PA 15213 Alain C. Borczuk, MDWeill Cornell University Medical CenterDepartment of Pathology1300 York AvenueStarr-1000ANew York, NY 10065 Keith M. Kerr, MDAberdeen University Medical SchoolAberdeen Royal InfirmaryDepartment of PathologyForesterhillAberdeen, Scotland Lynette Sholl, MDBrigham And Women's HospitalDepartment of Pathology75 Francis StBoston, MA 02115 Bryce Portier, MDHouston Methodist HospitalDepartment of Pathology & Genomic Medicine6565 Fannin StHouston, TX 77030 Eric Bernicker, MDHouston Methodist HospitalThoracic Medical Oncology6445 Main St, Floor 21Houston, TX 77030 

Weitere Details